SAN FRANCISCO, July  09, 2026  (GLOBE NEWSWIRE) -- Gildan Activewear (NYSE: GIL) investors saw the p...

SAN FRANCISCO, July  09, 2026  (GLOBE NEWSWIRE) -- Gildan Activewear (NYSE: GIL) investors saw the price of their shares in the activewear apparel company tumble over 18% on June 16 after Jehoshaphat Research published a critical forensic research report accusing Gildan of having engaged in improper channel stuffing. This news wiped out $2.15 billion from the company’s market capitalization.  These developments have prompted national shareholder rights firm Hagens Berman to open an investigation into whether Jehoshaphat’s allegations are accurate and, if so, whether Gildan may have violated the federal securities laws.  The firm encourages Gildan investors who purchased shares on the NYSE only and suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge about Gildan’s sales practices to contact the firm’s attorneys.  Visit: www.hbsslaw.com/investor-fraud/gil Contact the Firm Now: GIL@hbsslaw.com                                         844-916-0895  Gildan Activewear Inc. (GIL) Investigation:  Gildan consistently has assured investors that its financial statements comply with applicable accounting rules, including those governing proper revenue recognition.  The company’s assurances may have come into question on June 16, 2026. That day, Jehoshaphat Research published a critical short report, “STUFFING ALL OF THE CHANNEL SOME OF THE TIME?” Jehoshaphat said it compiled “field evidence” consisting of interviews with former employees, customers, or distributors that, in part, led the firm to conclude Gildan has engaged in improper channel stuffing and revenue recognition.  The sources reportedly “described some version of GIL ‘asking for help’ from or even ‘compel[ling]’ its customers to pull forward sales at quarter-ends, including by offering extreme payment terms[.]” The firm’s sources also reportedly “described a practice in which GIL is understood to be providing product to distributors & customers but not requiring payment until after the customer has resold it.” Jehoshaphat also reported that a former Gildan employee divulged that “[i]f there was a sense that we might not hit the sales numbers that we had communicated to the market, the sales team would offer incentives to the distributors to take on more weeks of supply than they normally had, or rebates at the end of the quarter, or more favorable payment terms[]” and “[t]hese are all mechanisms that were used to compel the distributors to bring forward some purchases.”  “Our investigation is focused on whether Jehoshaphat’s analysis is accurate and, if so, whether Gildan has engaged in improper revenue recognition practices,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.  If you invested in Gildan on the NYSE and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now »  If you’d like more information and answers to other frequently asked questions about the firm’s Gildan investigation, read more »  Whistleblowers: Persons with non-public information regarding Gildan should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email GIL@hbsslaw.com.  About Hagens BermanHagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.   Attorney Advertising. Prior results do not guarantee a similar outcome in any future case.  Contact: Reed Kathrein, 844-916-0895

Gildan Activewear Inc. (GIL) Shares Tumble 18% Amid Activist Forensic Report Challenging Company's Business Practices And Potentially Improper Revenue Recognition -- HBSS

Gildan faces material probe over channel stuffing allegations, impacting shares

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>SAN FRANCISCO, July  09, 2026  (GLOBE NEWSWIRE) -- Gildan Activewear (NYSE: GIL) investors saw the p...</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Negative headlines over potential improper revenue practices at Gildan have triggered a sharp stock reaction and raised questions about the quality of reported results. The Jehoshaphat Research report and the subsequent Hagens Berman inquiry create a near-term regulatory and legal risk, potentially pressuring margins, earnings credibility, and the stock multiple until clarifications emerge.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Jehoshaphat Research alleges channel stuffing at Gildan; revenue practices scrutinized.</li><li>Shares dropped ~18% on June 16; $2.15B market cap wiped.</li><li>Hagens Berman opened an investigation into Jehoshaphat&#039;s allegations.</li><li>Allegations focus on end-quarter pushes, rebates, and payment terms.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Gildan Activewear Inc. (GIL)</strong>: Subject of allegations; potential impact on revenue recognition credibility and valuation.</li><li><strong>Jehoshaphat Research (N/A)</strong>: Short report alleging improper channel stuffing; catalyst for stock volatility.</li><li><strong>Hagens Berman (N/A)</strong>: Investor-law firm leading inquiry; could trigger broader legal actions.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>This is a Legal category piece centered on an ongoing securities-law inquiry into GIL. It also interfaces with Corporate Developments due to potential restatement risk and governance implications.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>GIL shares fell ~18% on June 16, signaling immediate downside risk.</li><li>Regulatory/legal investigations may threaten restatements and future earnings.</li><li>Channel stuffing allegations could trigger increased scrutiny from auditors.</li><li>Whistleblower incentives and SEC program may drive further developments.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Date: July 9, 2026; Globe Newswire announced Gildan Activewear coverage.</li><li>June 16, 2026: GIL down over 18% after Jehoshaphat report.</li><li>Market capitalization impact cited as about $2.15 billion wiped.</li><li>Hagens Berman opened an investigation into Jehoshaphat&#039;s allegations.</li><li>SEC whistleblower program may reward up to 30% of recoveries.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bearish near-term until the investigation clarifies revenue practices and potential restatements.</p>
  </section>
</section>


<article>
  <h2>Gildan Activewear Shares Fall About 18% After Forensic Report, Triggering Hagens Berman Investigation Into Revenue Practices</h2>
  <p>SAN FRANCISCO, July 9, 2026 — Gildan Activewear Inc. (<strong>GIL</strong>) shares fell more than <strong>18%</strong> on <strong>June 16</strong> after Jehoshaphat Research published a forensic report accusing the company of improper channel stuffing. The decline <strong>wiped out $2.15 billion</strong> from Gildan’s market capitalization. National shareholder rights firm Hagens Berman has opened an investigation to determine whether Jehoshaphat’s allegations are accurate and whether <strong>GIL</strong> may have violated federal securities laws. The firm is encouraging Gildan investors who purchased shares on the NYSE and suffered substantial losses to submit their losses, and it is seeking individuals with knowledge about Gildan’s sales practices to contact the firm’s attorneys.</p>

  <section>
    <h3>Overview: Market reaction and the new inquiry</h3>
    <p>The developments surrounding <strong>Gildan Activewear</strong> prompted scrutiny of the company’s accounting practices and prompted calls for transparency as investors weigh potential implications for <em>earnings</em> quality and financial reporting. Hagens Berman states it is examining whether Jehoshaphat’s analysis is accurate and, if so, whether Gildan has engaged in improper revenue recognition practices.</p>
    <ul>
      <li>Stock symbol: <strong>GIL</strong> (NYSE)</li>
      <li>Price impact: <strong>over 18%</strong> drop on June 16</li>
      <li>Market capitalization impact: <strong>$2.15 billion</strong> wiped out</li>
      <li>Investigative focus: potential improper channel stuffing and revenue recognition</li>
    </ul>
  </section>

  <section>
    <h3>Jehoshaphat Research allegations: What the report claims</h3>
    <p>On June 16, Jehoshaphat Research published a critical short report, “<em>STUFFING ALL OF THE CHANNEL SOME OF THE TIME?</em>” The firm said it compiled <em>“field evidence”</em> consisting of interviews with former employees, customers, or distributors that, in part, led the firm to conclude Gildan has engaged in improper channel stuffing and revenue recognition.</p>
    <p>The sources reportedly <em>“described some version of GIL ‘asking for help’ from or even ‘compel[ling]’ its customers to pull forward sales at quarter-ends, including by offering extreme payment terms[.]”</em> The firm’s sources also reportedly <em>“described a practice in which GIL is understood to be providing product to distributors & customers but not requiring payment until after the customer has resold it.”</em></p>
    <p>“<em>Our investigation is focused on whether Jehoshaphat’s analysis is accurate and, if so, whether Gildan has engaged in improper revenue recognition practices,</em>” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.</p>
  </section>

  <section>
    <h3>Investor actions and whistleblower guidance</h3>
    <p>If you invested in <strong>Gildan</strong> on the NYSE and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now. If you’d like more information and answers to other frequently asked questions about the firm’s Gildan investigation, read more.</p>
    <p>Whistleblowers: Persons with non-public information regarding Gildan should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at <strong>844-916-0895</strong> or email <strong>GIL@hbsslaw.com</strong>.</p>
    <ul>
      <li>Visit the firm’s information hub: <a href="http://www.hbsslaw.com/investor-fraud/gil">www.hbsslaw.com/investor-fraud/gil</a></li>
      <li>Contact the Firm Now: <strong>GIL@hbsslaw.com</strong></li>
      <li>Phone: <strong>844-916-0895</strong></li>
    </ul>
  </section>

  <section>
    <h3>About Hagens Berman</h3>
    <p><strong>Hagens Berman</strong> is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than <strong>$2.9 billion</strong> in this area of law. More about the firm and its successes can be found at <a href="https://hbsslaw.com">hbsslaw.com</a>. Follow the firm for updates and news at <em>@ClassActionLaw</em>. Attorney Advertising. Prior results do not guarantee a similar outcome in any future case. Contact: Reed Kathrein, <strong>844-916-0895</strong>.</p>
  </section>
</article>

Negative headlines over potential improper revenue practices at Gildan have triggered a sharp stock reaction and raised questions about the quality of reported results. The Jehoshaphat Research report and the subsequent Hagens Berman inquiry create a near-term regulatory and legal risk, potentially pressuring margins, earnings credibility, and the stock multiple until clarifications emerge.

gildan-activewear-inc-gil-shares-tumble-18-amid-activist-forensic-report-challenging-company-s-business-practices-and-potentially-improper-revenue-recognition-hbss

Gildan Activewear Inc. (GIL) Shares Tumble 18% Amid Activist Forensic Report Challenging Company's Business Practices And Potentially Improper Revenue Recognition -- HBSS

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News